Movement disorders.
Movement disorders are commonly encountered in clinical practice. The diagnosis of movement disorders relies on a focused history and neurologic examination. Diagnostic steps include (1) identification of the phenomenology of the movements (eg, tremor); (2) characterization of appropriate clinical syndromes; and (3) differential diagnosis of specific disease entities. Accurate diagnosis is essential because symptomatic treatment exists for most movement disorders.
Cersosimo
Maria Graciela
MG
Movement Disorder Program, Hospital de Clinicas Jose de San Martin, University of Buenos Aires, Buenos Aires, Argentina.
Koller
William C
WC
D000328:Adult; D000368:Aged; D000927:Anticonvulsants / Q000627:therapeutic use; D001284:Atrophy / Q000473:pathology; D001921:Brain / Q000473:pathology; D002648:Child; D002998:Clonazepam / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D006816:Huntington Disease / Q000175:diagnosis*; D020961:Lewy Body Disease / Q000175:diagnosis*; D008297:Male; D008875:Middle Aged; D019578:Multiple System Atrophy / Q000175:diagnosis*; D009207:Myoclonus / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology*; D009460:Neurologic Examination; D010300:Parkinson Disease / Q000175:diagnosis* / Q000188:drug therapy; D013131:Spine / Q000503:physiopathology*; D014103:Torticollis / Q000175:diagnosis* / Q000188:drug therapy; D005879:Tourette Syndrome / Q000175:diagnosis* / Q000188:drug therapy; D017211:Treatment Failure; D014202:Tremor / Q000175:diagnosis* / Q000188:drug therapy / Q000523:psychology*
D000927:Anticonvulsants; D002998:Clonazepam